N. Saigi-Morgui

Discipline

Psychologie (3) Education (1)

Type de document

Articles (14) Mémoires, Thèses et HDR (1) Autres (1)

Co-auteur

Date

Source

Mot-clé

Patients (11) Patients (11) Treatment (10) association (9) Social groups (9) Psychotropic drugs (9) Human beings (9) poids (8) risque (8) adulte (8) Weight gain (8) Risk (8) Population (8) Weight (8) Population (8) adulte (8) Older people (7) Body mass index (7) Development (6) Psychotherapy patients (6) Obesity (6) Months (6) cohorte (6) santé (5) âge (5) Year (5) Triglycerides (5) Health (5) Age (5) Metabolic syndrome (5)

Documents écrit par N. Saigi-Morgui (15) | parle de N. Saigi-Morgui (0)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (7 oct. 2021)
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (26 juin 2021)
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.
A. Delacrétaz et al. (2018)
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs.
A. Delacrétaz et al.
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
A. Delacrétaz et al. (10 sept. 2017)
Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study.
N. Sikhayeva et al. (24 juil. 2017)
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
F. Vandenberghe et al.
Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression.
L. Quteineh et al. (1 juil. 2016)
PHARMACOGENETIC STUDY ON METABOLIC DISORDERS INDUCED BY PSYCHOTROPIC AND IMMUNOSUPPRESSANT DRUGS
N. Saigi-Morgui
Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.
N. Saigi-Morgui et al. (2016)
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
N. Saigi-Morgui et al. (2016)
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
N. Saigi-Morgui et al. (2015)
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.
A. Delacrétaz et al. (2015)
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
L. Quteineh et al. (2015)
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
F. Vandenberghe et al. (2015)